BGLC - Company ID 0001737523
The table below shows BioNexus Gene Lab Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.49M | - | - | - | $2.12M | $2.79M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $505.88K | - | - | - | - | - |
| Inventory | $676.70K | $1.39M | $1.14M | $977.81K | $1.52M | $1.18M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $5.45M |
| $7.43M |
| $8.05M |
| $6.02M |
| $7.15M |
| $7.99M |
| Property, plant & equipment | $1.60M | $1.52M | $1.51M | $1.51M | $1.63M | $1.79M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $9.25M | $10.43M | $11.40M | $8.74M | $9.57M | $10.12M |
| Accounts payable | - | $1.50M | $1.40M | $1.86M | - | - |
| Total current liabilities | $520.96K | $1.95M | $1.63M | $2.00M | $2.33M | $3.37M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $637.86K | $2.11M | $1.74M | $2.08M | $2.39M | $3.45M |
| Retained earnings | -$6.43M | -$3.44M | -$1.84M | $1.16M | $1.51M | $760.79K |
| Total equity | $8.61M | $8.32M | $9.66M | $6.67M | $7.18M | $6.66M |